Bulahan, Allea Claire B.
HRN: 26-33-70 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/06/2024
CEFUROXIME 250MG/5ML, 50ML SUSPENSION (BOT)
12/06/2024
12/13/2024
PO
3.5 ML
Q8h
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes